← Back to All Filings

New Director Joins Relay Therapeutics ($RLAY) Board, Files Form 3

Low SignificanceNovember 6, 2025 at 4:33:05 PM EST

Relay Therapeutics, Inc.

$RLAY3CIK: 0001812364

Subscribe to track RLAY

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

New Director Joins Relay Therapeutics ($RLAY) Board

Company: Relay Therapeutics, Inc. (RLAY) Form: 3 | Filed: 2025-11-06 Significance: Low

Insider: Dable Habib J Title: Director | Relationship: Director

Transaction: • Type: Initial Ownership Statement • Shares Owned: 0

Key Insight: A new director, Habib J Dable, has joined the board and filed a Form 3 reporting no initial beneficial ownership of company securities. This is a standard corporate governance event.

Market Context: This filing establishes a baseline for a new insider. Future Form 4 filings will track any subsequent buying or selling activity.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: Relay Therapeutics, Inc. (RLAY)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Habib J Dable has been appointed as a new Director at Relay Therapeutics and filed an initial statement of ownership, reporting zero holdings.
  • Market Impact: Neutral. This is a standard procedural filing required for new insiders.

Company Information

FieldValue
CompanyRelay Therapeutics, Inc.
Ticker SymbolRLAY
CIK0001812364
IndustryBIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

FieldValue
NameDable Habib J
CIK0001690773
Title/PositionDirector
RelationshipDirector

Transaction Details

This is a Form 3, an initial statement of beneficial ownership. The filing indicates that the reporting person does not own any securities of the company as of the reporting date.

FieldValue
Form Type3
Event Date2025-11-04
Shares Owned0

Financial Impact Assessment

As this is an initial statement of ownership with no securities held, there is no transaction to analyze. Therefore, metrics such as transaction value, percentage of market cap, and percentage of shares outstanding are not applicable.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The filing of a Form 3 is a routine administrative event that signals the appointment of a new insider. It does not involve a transaction and carries no direct market signal.

Volume & Sentiment

  • Expected Volume Impact: Negligible. This type of filing does not typically influence trading volume.
  • Sentiment Indicator: Neutral. The market sentiment is unlikely to be affected by this procedural filing.

Additional Context

Transaction Notes

  • This filing establishes the baseline ownership for a new director. Any future transactions in the company's stock by this insider will be reported on a Form 4.
Topics:#SECFiling#Form3#RLAY#RelayTherapeutics#InsiderTrading#CorporateGovernance#StockMarket#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.